+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Hyperparathyroidism - Pipeline Insight, 2024 - Product Thumbnail Image

Hyperparathyroidism - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Leukemia Therapeutics Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Leukemia Therapeutics Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Hairy Cell Leukemia Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Hairy Cell Leukemia Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Oncology Biosimilars Market Report 2025 - Product Thumbnail Image

Oncology Biosimilars Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Biosimilar Hormones Market Report 2025 - Product Thumbnail Image

Biosimilar Hormones Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Biosimilar Interleukins Market Report 2025 - Product Thumbnail Image

Biosimilar Interleukins Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Biosimilar Therapeutic Peptides Market Report 2025 - Product Thumbnail Image

Biosimilar Therapeutic Peptides Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
Loading Indicator